These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28191673)

  • 1. Acquired hair curling after diphenylcyclopropenone immunotherapy in alopecia areata patient.
    Choe SJ; Kim BJ; Choi J; Lee WS
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e371-e372. PubMed ID: 28191673
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema Multiforme Major After Immunotherapy With Diphenylcyclopropenone for Alopecia Areata.
    Sanger J; Zahir A; Driscoll M; Gaspari AA
    Dermatitis; 2018; 29(6):348-349. PubMed ID: 30346328
    [No Abstract]   [Full Text] [Related]  

  • 9. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 10. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases.
    Pericin M; Trüeb RM
    Dermatology; 1998; 196(4):418-21. PubMed ID: 9669118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata in a patient with candidiasis-endocrinopathy syndrome: unsuccessful treatment trial with diphenylcyclopropenone.
    Böni R; Trüeb RM; Wüthrich B
    Dermatology; 1995; 191(1):68-71. PubMed ID: 8589491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Onset of the effect in treatment of alopecia areata with diphenylcyclopropenone].
    Perret CM
    Hautarzt; 1989 May; 40(5):319. PubMed ID: 2500410
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
    Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases.
    Nam KH; Lee GJ; Kim JI; Song KH; Park J
    J Dermatol; 2023 Aug; 50(8):1093-1095. PubMed ID: 37334761
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
    Nasimi M; Abedini R; Ghandi N; Seirafi H; Mehdizade MS; Tootoonchi N
    Dermatol Ther; 2020 Nov; 33(6):e13808. PubMed ID: 32530566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.